Keywords: pfizer, celsentri, gets, european, commission, approval, patients

Pfizer's Celsentri gets European Commission approval for patients infected with HIV-1 CCR5-tropic virus

Article | 01 October 2007

Print This

US drug giant Pfizer says that the European Commission has approved its drug Celsentri (maraviroc) for treatment experienced HIV patients. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in